tiprankstipranks
Trending News
More News >
Biovaxys Technology Corp (BVAXF)
:BVAXF
US Market

BioVaxys Technology (BVAXF) Financial Statements

Compare
32 Followers

BioVaxys Technology Financial Overview

BioVaxys Technology's market cap is currently $5.82M. The company's EPS TTM is $-0.016; its P/E ratio is ―; BioVaxys Technology is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating IncomeC$ -3.30MC$ -2.40MC$ -4.08MC$ -6.42MC$ -1.09M
EBITDAC$ -3.95MC$ -7.69MC$ 0.00C$ 0.00C$ 0.00
Net IncomeC$ -3.95MC$ -7.69MC$ -19.36MC$ -6.47MC$ -1.18M
Balance Sheet
Cash & Short-Term InvestmentsC$ 211.81KC$ 977.00C$ 141.90KC$ 593.12KC$ 2.42M
Total AssetsC$ 1.30MC$ 113.48KC$ 865.56KC$ 8.50MC$ 10.46M
Total DebtC$ 68.08KC$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -143.73KC$ -977.00C$ -141.90KC$ -593.12KC$ -2.42M
Total LiabilitiesC$ 3.22MC$ 3.49MC$ 1.64MC$ 326.86KC$ 900.09K
Stockholders' EquityC$ -1.92MC$ -3.37MC$ -773.53KC$ 8.18MC$ 9.56M
Cash Flow
Free Cash FlowC$ -2.92MC$ -1.05MC$ -1.57MC$ -5.29MC$ -1.23M
Operating Cash FlowC$ -1.86MC$ -1.05MC$ -1.57MC$ -5.29MC$ -1.23M
Investing Cash FlowC$ -1.06MC$ 0.00C$ 0.00C$ 0.00C$ 61.36K
Financing Cash FlowC$ 3.13MC$ 917.10KC$ 1.11MC$ 3.44MC$ 3.35M
Currency in CAD

BioVaxys Technology Earnings and Revenue History

BioVaxys Technology Debt to Assets

BioVaxys Technology Cash Flow

BioVaxys Technology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis